Nutramax Cosequin 80 Sprinkle Capsules for Cats


$19.99

Nutramax Cosequin 80 Sprinkle Capsules for Cats

Cosequin for Cats is a dietary complement to assist your pet keep wholesome joints. As your pet ages, it’s frequent for his joints to develop into much less versatile, which impacts his mobility and high quality of life. Cosequin is the highest really useful model of veterinarians to assist and keep the well being of your cat’s joints. The one joint well being complement model that has been proven protected, efficient, and bioavailable in peer-reviewed, printed, managed, U. S. veterinary research. Cosequin for Cats helps assist cartilage manufacturing and defend present cartilage from breakdown. It’s manufactured following requirements much like these practiced by the pharmaceutical trade. Every capsule incorporates at the very least 125 milligrams of Glucosamine Hydrochloride, 100 milligrams of Sodium Chondroitin Sulfate, and 1 milligram of Manganese. Please learn all label info on supply. Indications: Cease Use Indications: Your veterinarian is your finest ally in managing your pet’s well being. In case your pet has any situation that requires medical consideration, you must at all times seek the advice of your veterinarian. Hold out of attain of youngsters. For animal use solely.
Is Discontinued By Producer ‏ : ‎ No
Product Dimensions ‏ : ‎ 1.75 x 1.75 x 3.5 inches; 1.45 ounces
Merchandise mannequin quantity ‏ : ‎ CQCAT80
Division ‏ : ‎ cat-hip-joint
Date First Out there ‏ : ‎ October 5, 2004
Producer ‏ : ‎ Nutramax Laboratories
ASIN ‏ : ‎ B000F4W02M
Nation of Origin ‏ : ‎ USA

Performs necessary function in sustaining optimum joint operate
Manufactured following requirements much like the pharmaceutical trade
Incorporates 125 milligrams FCHG49 Glucosamine and 100 milligrams TRH122 Chondroitin Sulfate per capsule
Please learn all label info on supply
[product_summary]

Based on 0 reviews

0.0 overall
0
0
0
0
0

Be the first to review “Nutramax Cosequin 80 Sprinkle Capsules for Cats”

There are no reviews yet.